Publication | Closed Access

Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers

Cancer ImmunosurveillanceAdvanced Lung DiseaseOncogenic AgentMedicineImmunologyPathologyTumor-infiltrating T CellsBronchial NeoplasmImmune Checkpoint InhibitorOncogenic DriversLung CancerPd-l2 ExpressionOncologyTumor MicroenvironmentTumor Biology